Articles for tag: Investing, Stocks

January 4, 2024

Ron Finklestien

AB InBev’s Growth Potential Pricing Actions, Premiumization to Aid AB InBev’s (BUD) Growth

Anheuser-Busch InBev SA/NV BUD, commonly known as AB InBev, is geared up for expansion due to sustained consumer demand for its brand portfolio. The company’s accelerated digital transformation, pricing actions, revenue management initiatives, and ongoing premiumization are propelling its growth trajectory. The company’s strategy has been centered around offering premium beer variants, aligning with the consumer premiumization trend in the alcohol industry. It has been committed to developing a diverse portfolio of global, international, and crafts and specialty premium brands within its markets. In addition to the premium brands, BUD’s global brands have been leading the charge in premiumization. AB

January 4, 2024

Ron Finklestien

The Whirlwind Rise of Wabtec (WAB): A Glimpse into What Fuels the Growth

Strong Growth and Raised Guidance Wabtec Corporation (WAB) has found itself riding high on the crest of a lucrative wave, largely due to the robust performance of its Freight segment. With an upward revision in its 2023 guidance, the company is looking at sales of $9.50-$9.70 billion, a significant raise from the previous projection of $9.25-$9.50 billion. Adjusted earnings per share are soaring to between $5.80 and $6.00, up from the earlier estimation of $5.50 and $5.80. This optimistic prognosis is enhanced by the foresight of strong cash flow generation with operating cash flow conversion anticipated to exceed 90%. Segmental

January 4, 2024

Ron Finklestien

Why Myriad Genetics (MYGN) Stock is a Solid Retain Why Myriad Genetics (MYGN) Stock is a Solid Retain

Myriad Genetics MYGN is poised for growth in the coming quarters, supported by a substantial improvement in testing volume across all its businesses. Despite this, it faces foreign exchange headwinds and stiff competition. Over the past year, the Zacks Rank #3 (Hold) stock has outperformed the industry with a 13.4% gain, compared to an industry decline of 8.6% and a 27.3% rise of the S&P 500 composite. The renowned genetic testing and precision medicine company has a market capitalization of $1.63 billion. Myriad Genetics surpassed estimates in three of the trailing four quarters and missed the same in one, delivering

January 4, 2024

Ron Finklestien

LG Display Unveils 480Hz QHD Gaming OLED Screens at CES 2024

LG Display is set to introduce an array of its latest Gaming Organic Light Emitting Diode (OLED) displays at the Consumer Electronics Show (CES) 2024. The company will introduce these high-quality QHD screens in various sizes during the mega consumer electronics show. The 27-inch version will be launched in the first half of the year for consumers. Revolutionary Pixel Technology Reportedly, the new gaming display features a refresh rate of 480Hz, powered by LG Display’s latest pixel technology, where each pixel emits light independently without depending on a backlight unit. This advanced feature will give gamers a smoother gameplay experience,

January 4, 2024

Ron Finklestien

Air Industries Soars with F-35 Contract Win Air Industries Soars with F-35 Contract Win

Air Industries Group’s AIRI business unit, Sterling Engineering Corporation, has sealed two contracts worth $3.2 million. The contracts entail supplying engine components for the F-135 jet engine powering the Lockheed Martin F-35 Lightning II. Deliveries are set to commence in early 2024. Unveiling the Wings of Triumph Lockheed Martin’s F-35 fleet flaunts cutting-edge features that make it an enticing choice for an array of nations. The company’s relentless pursuit of modernization to enhance the fighter jet with advanced technologies, keeping pace with contemporary warfare requisites, is propelling its demand. The U.S. government has set its sight on owning 2,456 F-35

January 4, 2024

Ron Finklestien

Why Stryker (SYK) Stock Should Be a Staple In Your Portfolio Why Stryker (SYK) Stock Should Be a Staple In Your Portfolio

Stryker Corporation SYK is set for a solid growth trajectory backed by a formidable robotic arm-assisted surgery platform, Mako, and a diverse product portfolio. The company has seen a 16.4% stock increase in the past year, far surpassing the industry’s 1.7% rise, and demonstrating a substantial leap compared to S&P 500 Index’s 23.8% upturn. With a market cap of $112.54 billion, Stryker is a leading player in the orthopedic market and projects a 10.1% growth in earnings over the next five years. SYK’s 3.9% earnings yield fares significantly better than the industry average of 0.8%. Image Source: Zacks Investment Research

January 4, 2024

Ron Finklestien

After An 11% Fall Last Year Is Humana A Better Pick Over UnitedHealth Stock?

Humana’s Attractive Valuation Indicates a Superior Pick Over UnitedHealth Group Stock The Battle of Titans: Humana vs. UnitedHealth Group Investing in stocks is akin to picking a prized racehorse at the Kentucky Derby. It takes a sharp eye to discern the steed with the most potential for a triumphant gallop. Such keen acumen is currently being put to the test as investors scrutinize the prospects of Humana and its counterpart, UnitedHealth Group. Market Performance and Historical Context The stock market, like the unpredictable weather, has demonstrated capricious behavior of late. From the stormy tempests of 2022 to the sunny skies

January 3, 2024

Ron Finklestien

Airline Stocks Set to Soar in 2024: A Look at Three High-Flyers

As we embark upon a new year, several airline stocks are catching the eye of investors, with a number of them occupying coveted spots on the Zacks Rank #1 (Strong Buy) list. The U.S. Department of Transportation revealed that the recent holiday travel season witnessed remarkable smoothness, with a mere 0.8% cancellation rate, a stark contrast to the 8.2% witnessed at the end of 2022. In fact, the cancellation rate for domestic flights in 2023 was below 1.2%, marking the lowest in a decade. SkyWest: Navigating the Skies with Promise Touting a Zacks Rank #1 (Strong Buy), SkyWest Airlines, a

January 3, 2024

Ron Finklestien

Opportunity Awaits: Agriculture Stocks to Buy for the New Year Opportunity Awaits: Agriculture Stocks to Buy for the New Year

Ripe for the Picking: A Bountiful Year for Agriculture Stocks After such an incredible year for the stock market in 2023, investors will certainly be looking for buy-the-dip candidates as a market pullback is to be expected at some point. In this regard, a few agriculture stocks are attractive as they look poised to move higher even as a potential correction for the broader market looms. With that being said, let’s check out the opportunity in two pleasantly intriguing Zacks Agriculture-Operations Industry stocks. Dole: Fresh Growth Potential Boasting a Zacks Rank #1 (Strong Buy) Dole’s stock is starting to look

January 3, 2024

Ron Finklestien

Ralph Lauren’s Digital Surge: A Bullish Outlook for 2024 Ralph Lauren’s Digital Surge: A Bullish Outlook for 2024

Amidst bullish sentiments, Ralph Lauren Corporation (RL) is charting a course for growth, propelled by a remarkable digital surge and robust strategies. With a steadfast focus on enhancing digital capabilities, deepening customer relationships, and expanding in international markets while managing expenses deftly, the company is positioning itself for a soaring trajectory. The Next Great Chapter Unfolds Efforts under the Next Great Chapter plan are yielding promising results. The successful transition of Chaps to a licensed business stands as a testament to Ralph Lauren’s portfolio realignment strategy. This strategic move has freed resources to concentrate on core brands, a pivotal element